Wexford Capital LP
WEXFORD CAPITAL LP, 10%, reported a transaction classified as exercise at NEPHROS INC involving 3765.000000 shares for an estimated $0.00. Reported holdings after the transaction were 36198.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
NEPH price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001398344-26-015086 Stock Option (Right to Buy)
- Transaction date
- Aug 18, 2026 Filed Aug 20, 2026, 08:14 PM · 2d delay
- Shares
- 3,765 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 36,198 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Represents the net number of shares of common stock issued upon the cashless exercise of stock options to purchase 3,765 shares, after a portion of the option shares was withheld to satisfy the exerci…
- F2
Includes shares of common stock granted to Wexford Capital LP ("Wexford Capital") as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wex…
- F3
One-third of the options vested immediately upon the grant date of August 24, 2016. The remainder of the options vested in equal annual installments on each of the first and second anniversaries of th…
- F4
Includes stock options granted to Wexford Capital as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.
0 other transactions
0 recent txs